Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1978 Nov;22(2):445–451. doi: 10.1128/iai.22.2.445-451.1978

Cellular and Humoral Immune Responses to Herpes Simplex Virus During and After Primary Gingivostomatitis

Anné Møller-Larsen 1, Sven Haahr 1, Finn T Black 2
PMCID: PMC422177  PMID: 730366

Abstract

A total of 17 children, aged 1 to 15 years, with gingivostomatitis were investigated to follow the development of immune parameters in those who suffered from herpes simplex virus stomatitis. Mouth swabs were obtained during the acute attack. Blood samples were collected on this occasion and again about 3 weeks later. Humoral immunity to herpes simplex virus was investigated by a complement fixation test and by an antibody-dependent cell-mediated cytotoxicity test. Cell-mediated immunity was investigated in a blast transformation assay with herpes simplex virus type 1 antigen and phytohemagglutinin. Interferon production in herpes-stimulated cultures was measured. Thirteen patients had a herpes simplex stomatitis. Twelve of these children were negative in the complement fixation test on the first serum specimen, but only five were negative in the antibody-dependent cell-mediated cytotoxicity test. These five were still febrile at the time of investigation. Blast transformation was negative at the first investigation in most children, whereas interferon was produced both in leukocyte cultures obtained during the infection and also in cultures made 3 to 4 weeks after the infection. An increase in immune parameters was seen in all patients with herpes stomatitis. From results in blast transformation and antibody-dependent cell-mediated cytotoxicity, it is seen that cell-mediated and humoral immunity can be found at the same time during recovery from this type of infection.

Full text

PDF
445

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amlot P. L., Pussell B., Slaney J. M., Williams B. D. Correlation between immune complexes and prognostic factors in Hodgkin's disease. Clin Exp Immunol. 1978 Feb;31(2):166–173. [PMC free article] [PubMed] [Google Scholar]
  2. Andersen H. K. Complement-fixing and virus-neutralizing antibodies in cytomegalovirus infection as measured against homologous and heterologous antigen. Acta Pathol Microbiol Scand B Microbiol Immunol. 1970;78(4):504–508. doi: 10.1111/j.1699-0463.1970.tb04334.x. [DOI] [PubMed] [Google Scholar]
  3. BUDDINGH G. J., SCHRUM D. I., LANIER J. C., GUIDRY D. J. Studies of the natural history of herpes simplex infections. Pediatrics. 1953 Jun;11(6):595–610. [PubMed] [Google Scholar]
  4. Buimovici-Klein E., Weiss K. E., Cooper L. Z. Interferon production in lymphocyte cultures after rubella infection in humans. J Infect Dis. 1977 Mar;135(3):380–385. doi: 10.1093/infdis/135.3.380. [DOI] [PubMed] [Google Scholar]
  5. Böyum A. Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyteaggregating agents. Scand J Clin Lab Invest Suppl. 1968;97:31–50. [PubMed] [Google Scholar]
  6. Haahr S., Rasmussen L., Merigan T. C. Lymphocyte transformation and interferon production in human mononuclear cell microcultures for assay of cellular immunity to herpes simplex virus. Infect Immun. 1976 Jul;14(1):47–54. doi: 10.1128/iai.14.1.47-54.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lopez C., O'Reilly R. J. Cell-mediated immune responses in recurrent herpesvirus infections. I. Lymphocyte proliferation assay. J Immunol. 1977 Mar;118(3):895–902. [PubMed] [Google Scholar]
  8. Merigan T. C., Stevens D. A. Viral infections in man associated with acquired immunological deficiency states. Fed Proc. 1971 Nov-Dec;30(6):1858–1864. [PubMed] [Google Scholar]
  9. Moller-Larsen A., Heron I., Haahr S. Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies. Infect Immun. 1977 Apr;16(1):43–47. doi: 10.1128/iai.16.1.43-47.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Muller S. A., Herrmann E. C., Jr, Winkelmann R. K. Herpes simplex infections in hematologic malignancies. Am J Med. 1972 Jan;52(1):102–114. doi: 10.1016/0002-9343(72)90012-5. [DOI] [PubMed] [Google Scholar]
  11. Møller-Larsen A., Haahr S. Humoral and cell-mediated immune responses in humans before and after revaccination with vaccinia virus. Infect Immun. 1978 Jan;19(1):34–39. doi: 10.1128/iai.19.1.34-39.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Nahmias A. J., Roizman B. Infection with herpes-simplex viruses 1 and 2. 3. N Engl J Med. 1973 Oct 11;289(15):781–789. doi: 10.1056/NEJM197310112891505. [DOI] [PubMed] [Google Scholar]
  13. Rager-Zisman B., Allison A. C. Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection. J Immunol. 1976 Jan;116(1):35–40. [PubMed] [Google Scholar]
  14. Rand K. H., Rasmussen L. E., Pollard R. B., Arvin A., Merigan T. C. Cellular immunity and herpesvirus infections in cardiac-transplant patients. N Engl J Med. 1977 Jun 16;296(24):1372–1377. doi: 10.1056/NEJM197706162962402. [DOI] [PubMed] [Google Scholar]
  15. Rasmussen L. E., Jordan G. W., Stevens D. A., Merigan T. C. Lymphocyte interferon production and transformation after Herpes simplex infections in humans. J Immunol. 1974 Feb;112(2):728–736. [PubMed] [Google Scholar]
  16. Rosenberg G. L., Notkins A. L. Induction of cellular immunity to herpes simplex virus: relationship to the humoral immune response. J Immunol. 1974 Mar;112(3):1019–1025. [PubMed] [Google Scholar]
  17. Rouse B. T., Grewal A. S., Babiuk L. A. Complement enhances antiviral antibody-dependent cell cytotoxicity. Nature. 1977 Mar 31;266(5601):456–458. doi: 10.1038/266456a0. [DOI] [PubMed] [Google Scholar]
  18. Russell A. S. Cell-mediated immunity to herpes simplex virus in man. Am J Clin Pathol. 1973 Dec;60(6):826–830. doi: 10.1093/ajcp/60.6.826. [DOI] [PubMed] [Google Scholar]
  19. Shillitoe E. J., Wilton J. M., Lehner T. Sequential changes in T and B lymphocyte responses to Herpes simplex virus in man. Scand J Immunol. 1978;7(5):357–366. doi: 10.1111/j.1365-3083.1978.tb00465.x. [DOI] [PubMed] [Google Scholar]
  20. Shore S. L., Black C. M., Melewicz F. M., Wood P. A., Nahmias A. J. Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus. J Immunol. 1976 Jan;116(1):194–201. [PubMed] [Google Scholar]
  21. Shore S. L., Cromeans T. L., Romano T. J. Immune destruction of virus-infected cells early in the infectious cycle. Nature. 1976 Aug 19;262(5570):695–696. doi: 10.1038/262695a0. [DOI] [PubMed] [Google Scholar]
  22. Shore S. L., Melewicz F. M., Gordon D. S. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. I. Identification of the population of effector cells. J Immunol. 1977 Feb;118(2):558–566. [PubMed] [Google Scholar]
  23. Steele R. W., Vincent M. M., Hensen S. A., Fuccillo D. A., Chapa I. A., Canales L. Cellular immune responses to Herpes simplex virus type 1 in recurrent herpes labialis: in vitro blastogenesis and cytotoxicity to infected cell line. J Infect Dis. 1975 May;131(5):528–534. doi: 10.1093/infdis/131.5.528. [DOI] [PubMed] [Google Scholar]
  24. Subramanian T., Rawls W. E. Comparison of antibody-dependent cellular cytotoxicity and complement-dependent antibody lysis of herpes simplex virus-infected cells as methods of detecting antiviral antibodies in human sera. J Clin Microbiol. 1977 Jun;5(6):551–558. doi: 10.1128/jcm.5.6.551-558.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Valle M. J., Jordan G. W., Haahr S., Merigan T. C. Characteristics of immune interferon produced by human lymphocyte cultures compared to other human interferons. J Immunol. 1975 Jul;115(1):230–233. [PubMed] [Google Scholar]
  26. Von Wowern N. Ginivo-stomatitis herpetica. En litteraturoversigt og en opgørelse af 44 egne tilfaelde. Ugeskr Laeger. 1971 May 7;133(18):877–880. [PubMed] [Google Scholar]
  27. Wisloff F., Froland S. S. Antibody-dependent lymphocyte-mediated cytotoxicity in man: no requirement for lymphocytes with membrane-bound immunoglobulin. Scand J Immunol. 1973;2(2):151–157. doi: 10.1111/j.1365-3083.1973.tb02026.x. [DOI] [PubMed] [Google Scholar]
  28. Ziegler H. K., Henney C. S. Studies on the cytotoxic activity of human lymphocytes. II. Interactions between IgG and Fc receptors leading to inhibition of K cell function. J Immunol. 1977 Sep;119(3):1010–1017. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES